Please join Foley Hoag and HGF for a webinar on the evolving role of artificial intelligence in biotechnology and the patent issues raised by AI-driven innovation in the life sciences.

Topics will include:

• Patentability considerations for software-related inventions, including the eligibility frameworks in the EPO and USPTO, and how to address the respective standards in the drafting phase.
• How AI differs from conventional software in the patent context, including recent USPTO guidance and related policy considerations.
• Key biotechnology applications of AI, including drug discovery, clinical support, diagnostics, and personalized medicine.
• Inventorship issues raised by AI-assisted innovation, including whether AI can or should be recognized as an inventor.

A question-and-answer session will follow the presentation.

Speakers:

• Erik Huestis, Partner, Co-Chair, Technology Industry Group - Foley Hoag
• Dr. Janine Swarbrick, Partner - HGF
• Dr. Beth Marshall, Patent Director - HGF 

CLE credit for this course is available in New York and California. This program is offering 1.0 Areas of Professional Practice CLE credit in NY, and 1.0 General CLE credit in CA. The program is appropriate for both newly admitted attorneys and experienced attorneys. Please contact us for details.

The session is also eligible for UK patent attorneys to be logged to meet IPReg’s Continuing Competence requirements.